Figure 2. Effect of ESWT on endothelial cells treated with GCs. (A–C) cell viability was examined by CCK-8 analysis in HUVECs; ECs were subjected to ESWT with 0.05 mJ/mm2, 1000 shots followed by DEX with 180 μM. (D) cell viability examined by CCK-8 analysis in BMECs; (E) cell proliferation confirmed by EdU assay in BMECs; ECs were subjected to ESWT with 0.03 mJ/mm2, 1000 shots followed by DEX with 180 μM. (F) apoptosis rate of assessed through Annexin V-FITC/PI in BMECs; ECs were subjected to ESWT with 0.05 mJ/mm2, 1000 shots followed by DEX with 180 μM. (G) migration ability evaluated by wound healing assay in BMECs; (H) migration ability evaluated by Transwell assay in BMECs; (I) angiogenesis ability evaluated by tube formation assay in BMECs. n=3 **P < .01, ***P < .001.